25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BMRA (Biomerica) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biomerica together

I guess you are interested in Biomerica Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Biomerica’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Biomerica’s Price Targets

I'm going to help you getting a better view of Biomerica Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biomerica Inc

I send you an email if I find something interesting about Biomerica Inc.

1. Quick Overview

1.1. Quick analysis of Biomerica (30 sec.)










1.2. What can you expect buying and holding a share of Biomerica? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.32
Expected worth in 1 year
$0.14
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.19
Return On Investment
-6.0%

For what price can you sell your share?

Current Price per Share
$3.15
Expected price per share
$2.88 - $4.2099
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biomerica (5 min.)




Live pricePrice per Share (EOD)
$3.15
Intrinsic Value Per Share
$-14.48 - $-1.96
Total Value Per Share
$-14.16 - $-1.64

2.2. Growth of Biomerica (5 min.)




Is Biomerica growing?

Current yearPrevious yearGrowGrow %
How rich?$5.5m$10.6m-$4.5m-74.8%

How much money is Biomerica making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$1.4m$123.4k9.1%
Net Profit Margin-110.2%-108.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biomerica (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#226 / 292

Most Revenue
#235 / 292

Most Profit
#149 / 292

Most Efficient
#225 / 292
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biomerica?

Welcome investor! Biomerica's management wants to use your money to grow the business. In return you get a share of Biomerica.

First you should know what it really means to hold a share of Biomerica. And how you can make/lose money.

Speculation

The Price per Share of Biomerica is $3.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biomerica.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biomerica, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.32. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biomerica.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-2.2%-0.08-2.5%-0.09-2.8%-0.10-3.2%-0.10-3.2%-0.07-2.3%
Usd Book Value Change Per Share0.020.8%-0.05-1.5%0.041.2%-0.04-1.2%0.000.0%-0.01-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.8%-0.05-1.5%0.041.2%-0.04-1.2%0.000.0%-0.01-0.3%
Usd Price Per Share0.73-0.67-1.19-1.68-3.20-2.86-
Price to Earnings Ratio-2.70--2.05--3.52--3.79--13.94--16.93-
Price-to-Total Gains Ratio29.96--3.48--9.47--25.62--180.86--150.09-
Price to Book Ratio2.27-1.81-1.88-3.18-4.48-4.78-
Price-to-Total Gains Ratio29.96--3.48--9.47--25.62--180.86--150.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.15
Number of shares317
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.00
Usd Total Gains Per Share-0.050.00
Gains per Quarter (317 shares)-14.87-0.31
Gains per Year (317 shares)-59.49-1.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-59-690-1-11
20-119-1280-2-12
30-178-1870-4-13
40-238-2460-5-14
50-297-3050-6-15
60-357-3640-7-16
70-416-4230-9-17
80-476-4820-10-18
90-535-5410-11-19
100-595-6000-12-20

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.05.00.00.0%0.012.00.00.0%0.021.00.00.0%1.039.00.02.5%49.084.09.034.5%
Book Value Change Per Share1.04.00.020.0%2.010.00.016.7%5.016.00.023.8%8.032.00.020.0%57.079.06.040.1%
Dividend per Share0.00.05.00.0%0.00.012.00.0%0.00.021.00.0%2.00.038.05.0%2.00.0140.01.4%
Total Gains per Share1.04.00.020.0%2.010.00.016.7%5.016.00.023.8%8.032.00.020.0%57.079.06.040.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biomerica Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.025-0.047+291%0.038-35%-0.036+249%-0.001+104%-0.010+139%
Book Value Per Share--0.3230.359-10%0.632-49%0.497-35%0.642-50%0.595-46%
Current Ratio--3.7623.576+5%6.281-40%4.655-19%5.168-27%5.767-35%
Debt To Asset Ratio--0.2500.280-11%0.194+29%0.253-1%0.266-6%0.221+13%
Debt To Equity Ratio--0.3330.391-15%0.240+38%0.343-3%0.379-12%0.314+6%
Dividend Per Share----0%-0%-0%-0%0.000-100%
Enterprise Value--13798543.31612591584.533+10%25811164.227-47%27007017.276-49%43137180.360-68%33005975.542-58%
Eps---0.068-0.080+18%-0.088+29%-0.100+48%-0.100+47%-0.074+9%
Ev To Ebitda Ratio---3.105-2.310-26%-4.571+47%-4.442+43%-172.329+5450%-103.783+3242%
Ev To Sales Ratio--3.0832.691+15%4.656-34%4.499-31%6.424-52%5.285-42%
Free Cash Flow Per Share---0.061-0.072+18%-0.071+16%-0.104+71%-0.085+39%-0.060-2%
Free Cash Flow To Equity Per Share--0.040-0.048+219%0.075-46%-0.045+211%0.012+237%0.008+379%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.961----------
Intrinsic Value_10Y_min---14.480----------
Intrinsic Value_1Y_max---0.232----------
Intrinsic Value_1Y_min---0.597----------
Intrinsic Value_3Y_max---0.671----------
Intrinsic Value_3Y_min---2.543----------
Intrinsic Value_5Y_max---1.077----------
Intrinsic Value_5Y_min---5.297----------
Market Cap8019144.000-57%12582543.31611388384.533+10%20073830.893-37%24259934.526-48%40589448.979-69%31631510.617-60%
Net Profit Margin---1.039-1.102+6%-1.080+4%-1.077+4%-0.941-9%-0.628-40%
Operating Margin---1.081-1.014-6%-1.117+3%-1.055-2%-0.955-12%-0.628-42%
Operating Ratio--2.0812.156-3%2.134-2%2.116-2%1.966+6%1.635+27%
Pb Ratio9.746+77%2.2741.814+25%1.878+21%3.179-28%4.485-49%4.784-52%
Pe Ratio-11.593-329%-2.705-2.052-24%-3.522+30%-3.787+40%-13.943+415%-16.931+526%
Price Per Share3.150+77%0.7350.673+9%1.193-38%1.680-56%3.195-77%2.856-74%
Price To Free Cash Flow Ratio-12.903-329%-3.010-2.321-23%-4.526+50%-4.142+38%-399.413+13169%-228.533+7492%
Price To Total Gains Ratio128.411+77%29.958-3.484+112%-9.467+132%-25.617+186%-180.857+704%-150.086+601%
Quick Ratio--2.6232.437+8%5.088-48%3.422-23%3.608-27%3.422-23%
Return On Assets---0.158-0.159+1%-0.112-29%-0.153-3%-0.127-20%-0.099-37%
Return On Equity---0.210-0.221+5%-0.140-34%-0.207-2%-0.172-18%-0.132-37%
Total Gains Per Share--0.025-0.047+291%0.038-35%-0.036+249%-0.001+104%-0.010+139%
Usd Book Value--5534000.0006078600.000-9%10625000.000-48%7678609.083-28%8669313.286-36%6720793.100-18%
Usd Book Value Change Per Share--0.025-0.047+291%0.038-35%-0.036+249%-0.001+104%-0.010+139%
Usd Book Value Per Share--0.3230.359-10%0.632-49%0.497-35%0.642-50%0.595-46%
Usd Dividend Per Share----0%-0%-0%-0%0.000-100%
Usd Enterprise Value--13798543.31612591584.533+10%25811164.227-47%27007017.276-49%43137180.360-68%33005975.542-58%
Usd Eps---0.068-0.080+18%-0.088+29%-0.100+48%-0.100+47%-0.074+9%
Usd Free Cash Flow---1045000.000-1213000.000+16%-1189272.333+14%-1540827.583+47%-1163585.667+11%-743842.850-29%
Usd Free Cash Flow Per Share---0.061-0.072+18%-0.071+16%-0.104+71%-0.085+39%-0.060-2%
Usd Free Cash Flow To Equity Per Share--0.040-0.048+219%0.075-46%-0.045+211%0.012+237%0.008+379%
Usd Market Cap8019144.000-57%12582543.31611388384.533+10%20073830.893-37%24259934.526-48%40589448.979-69%31631510.617-60%
Usd Price Per Share3.150+77%0.7350.673+9%1.193-38%1.680-56%3.195-77%2.856-74%
Usd Profit---1163000.000-1353600.000+16%-1477059.000+27%-1525501.750+31%-1375932.286+18%-897750.025-23%
Usd Revenue--1119000.0001339000.000-16%1462736.000-23%1718018.417-35%2156491.667-48%1781710.525-37%
Usd Total Gains Per Share--0.025-0.047+291%0.038-35%-0.036+249%-0.001+104%-0.010+139%
 EOD+4 -4MRQTTM+29 -8YOY+12 -253Y+20 -175Y+18 -1910Y+12 -28

3.3 Fundamental Score

Let's check the fundamental score of Biomerica Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.593
Price to Book Ratio (EOD)Between0-19.746
Net Profit Margin (MRQ)Greater than0-1.039
Operating Margin (MRQ)Greater than0-1.081
Quick Ratio (MRQ)Greater than12.623
Current Ratio (MRQ)Greater than13.762
Debt to Asset Ratio (MRQ)Less than10.250
Debt to Equity Ratio (MRQ)Less than10.333
Return on Equity (MRQ)Greater than0.15-0.210
Return on Assets (MRQ)Greater than0.05-0.158
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Biomerica Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.704
Ma 20Greater thanMa 503.224
Ma 50Greater thanMa 1003.338
Ma 100Greater thanMa 2004.144
OpenGreater thanClose3.280
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Biomerica Inc

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California.

Fundamental data was last updated by Penke on 2025-07-10 22:42:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Biomerica earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Biomerica to theΒ Medical Devices industry mean.
  • A Net Profit Margin of -103.9%Β means thatΒ $-1.04 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biomerica Inc:

  • The MRQ is -103.9%. The company is making a huge loss. -2
  • The TTM is -110.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-103.9%TTM-110.2%+6.2%
TTM-110.2%YOY-108.0%-2.2%
TTM-110.2%5Y-94.1%-16.0%
5Y-94.1%10Y-62.8%-31.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-103.9%-7.9%-96.0%
TTM-110.2%-10.4%-99.8%
YOY-108.0%-13.5%-94.5%
3Y-107.7%-14.5%-93.2%
5Y-94.1%-10.7%-83.4%
10Y-62.8%-11.1%-51.7%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Biomerica is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Biomerica to theΒ Medical Devices industry mean.
  • -15.8% Return on Assets means thatΒ Biomerica generatedΒ $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biomerica Inc:

  • The MRQ is -15.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.8%TTM-15.9%+0.1%
TTM-15.9%YOY-11.2%-4.7%
TTM-15.9%5Y-12.7%-3.2%
5Y-12.7%10Y-9.9%-2.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.8%-2.1%-13.7%
TTM-15.9%-2.4%-13.5%
YOY-11.2%-3.5%-7.7%
3Y-15.3%-2.9%-12.4%
5Y-12.7%-2.7%-10.0%
10Y-9.9%-2.4%-7.5%
4.3.1.3. Return on Equity

Shows how efficient Biomerica is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Biomerica to theΒ Medical Devices industry mean.
  • -21.0% Return on Equity means Biomerica generated $-0.21Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biomerica Inc:

  • The MRQ is -21.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.0%TTM-22.1%+1.1%
TTM-22.1%YOY-14.0%-8.1%
TTM-22.1%5Y-17.2%-4.9%
5Y-17.2%10Y-13.2%-4.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.0%-2.0%-19.0%
TTM-22.1%-3.2%-18.9%
YOY-14.0%-3.9%-10.1%
3Y-20.7%-4.0%-16.7%
5Y-17.2%-4.4%-12.8%
10Y-13.2%-6.3%-6.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biomerica Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Biomerica is operatingΒ .

  • Measures how much profit Biomerica makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Biomerica to theΒ Medical Devices industry mean.
  • An Operating Margin of -108.1%Β means the company generated $-1.08 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biomerica Inc:

  • The MRQ is -108.1%. The company is operating very inefficient. -2
  • The TTM is -101.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-108.1%TTM-101.4%-6.7%
TTM-101.4%YOY-111.7%+10.3%
TTM-101.4%5Y-95.5%-5.9%
5Y-95.5%10Y-62.8%-32.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-108.1%-12.1%-96.0%
TTM-101.4%-13.7%-87.7%
YOY-111.7%-11.9%-99.8%
3Y-105.5%-11.3%-94.2%
5Y-95.5%-10.3%-85.2%
10Y-62.8%-12.2%-50.6%
4.3.2.2. Operating Ratio

Measures how efficient Biomerica is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 2.08 means that the operating costs are $2.08 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biomerica Inc:

  • The MRQ is 2.081. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.156. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.081TTM2.156-0.075
TTM2.156YOY2.134+0.022
TTM2.1565Y1.966+0.190
5Y1.96610Y1.635+0.331
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0811.397+0.684
TTM2.1561.389+0.767
YOY2.1341.295+0.839
3Y2.1161.342+0.774
5Y1.9661.375+0.591
10Y1.6351.328+0.307
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biomerica Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biomerica is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 3.76Β means the company has $3.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biomerica Inc:

  • The MRQ is 3.762. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.576. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.762TTM3.576+0.187
TTM3.576YOY6.281-2.705
TTM3.5765Y5.168-1.592
5Y5.16810Y5.767-0.599
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7622.473+1.289
TTM3.5762.589+0.987
YOY6.2812.630+3.651
3Y4.6552.884+1.771
5Y5.1683.528+1.640
10Y5.7673.291+2.476
4.4.3.2. Quick Ratio

Measures if Biomerica is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Biomerica to theΒ Medical Devices industry mean.
  • A Quick Ratio of 2.62Β means the company can pay off $2.62 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biomerica Inc:

  • The MRQ is 2.623. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.437. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.623TTM2.437+0.186
TTM2.437YOY5.088-2.650
TTM2.4375Y3.608-1.170
5Y3.60810Y3.422+0.186
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6231.079+1.544
TTM2.4371.398+1.039
YOY5.0881.638+3.450
3Y3.4221.815+1.607
5Y3.6082.139+1.469
10Y3.4222.338+1.084
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biomerica Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BiomericaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Biomerica to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.25Β means that Biomerica assets areΒ financed with 25.0% credit (debt) and the remaining percentage (100% - 25.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Biomerica Inc:

  • The MRQ is 0.250. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.280. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.250TTM0.280-0.030
TTM0.280YOY0.194+0.086
TTM0.2805Y0.266+0.014
5Y0.26610Y0.221+0.045
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2500.409-0.159
TTM0.2800.419-0.139
YOY0.1940.401-0.207
3Y0.2530.391-0.138
5Y0.2660.424-0.158
10Y0.2210.457-0.236
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Biomerica is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Biomerica to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 33.3% means that company has $0.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biomerica Inc:

  • The MRQ is 0.333. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.391. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.333TTM0.391-0.058
TTM0.391YOY0.240+0.151
TTM0.3915Y0.379+0.012
5Y0.37910Y0.314+0.064
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3330.608-0.275
TTM0.3910.648-0.257
YOY0.2400.623-0.383
3Y0.3430.644-0.301
5Y0.3790.683-0.304
10Y0.3140.757-0.443
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Biomerica generates.

  • Above 15 is considered overpriced butΒ always compareΒ Biomerica to theΒ Medical Devices industry mean.
  • A PE ratio of -2.70 means the investor is paying $-2.70Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biomerica Inc:

  • The EOD is -11.593. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.705. Based on the earnings, the company is expensive. -2
  • The TTM is -2.052. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.593MRQ-2.705-8.889
MRQ-2.705TTM-2.052-0.653
TTM-2.052YOY-3.522+1.470
TTM-2.0525Y-13.943+11.891
5Y-13.94310Y-16.931+2.988
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-11.593-1.295-10.298
MRQ-2.705-1.518-1.187
TTM-2.052-1.257-0.795
YOY-3.522-2.406-1.116
3Y-3.787-1.572-2.215
5Y-13.943-1.938-12.005
10Y-16.931-1.705-15.226
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biomerica Inc:

  • The EOD is -12.903. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.010. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.321. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.903MRQ-3.010-9.892
MRQ-3.010TTM-2.321-0.689
TTM-2.321YOY-4.526+2.205
TTM-2.3215Y-399.413+397.092
5Y-399.41310Y-228.533-170.879
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-12.903-2.842-10.061
MRQ-3.010-3.183+0.173
TTM-2.321-1.612-0.709
YOY-4.526-3.401-1.125
3Y-4.142-2.458-1.684
5Y-399.413-3.239-396.174
10Y-228.533-3.398-225.135
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Biomerica is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 2.27 means the investor is paying $2.27Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biomerica Inc:

  • The EOD is 9.746. Based on the equity, the company is overpriced. -1
  • The MRQ is 2.274. Based on the equity, the company is underpriced. +1
  • The TTM is 1.814. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.746MRQ2.274+7.472
MRQ2.274TTM1.814+0.459
TTM1.814YOY1.878-0.063
TTM1.8145Y4.485-2.670
5Y4.48510Y4.784-0.300
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD9.7462.030+7.716
MRQ2.2741.966+0.308
TTM1.8142.162-0.348
YOY1.8782.656-0.778
3Y3.1792.683+0.496
5Y4.4853.822+0.663
10Y4.7844.189+0.595
4.6.2. Total Gains per Share

2.4. Latest News of Biomerica Inc

Does Biomerica Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Biomerica Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-02
20:29
Biomerica Secures PLA Code For InFoods IBS Test, Advancing Reimbursement AccessRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biomerica Inc.

4.8.1. Institutions holding Biomerica Inc

Institutions are holding 5.805% of the shares of Biomerica Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Group Inc0.8299016901000
2025-03-31Geode Capital Management, LLC0.768801565833808032.1342
2025-03-31BlackRock Inc0.732014908100
2025-03-31Bulltick Wealth Management LLC0.67340.02061371491371490
2025-03-31Granahan Investment Management Inc..0.43190.002587968-570799-86.6466
2025-03-31Two Sigma Investments LLC0.2080.000142362423620
2025-03-31State Street Corp0.182803723100
2025-03-31Goss Wealth Management LLC0.14290.00012910000
2025-03-31TWO SIGMA SECURITIES, LLC0.11560.00223542-31653-57.3476
2025-03-31Northern Trust Corp0.101402066100
2025-03-31Group One Trading, LP0.09460192601922149284.6154
2025-03-31UBS Group AG0.08016288-6965-29.9531
2025-03-31HRT FINANCIAL LLC0.062012621-24033-65.5672
2025-03-31Susquehanna International Group, LLP0.0615012528-16893-57.4182
2025-03-31Hollencrest Securities, LLC0.0570.00031160000
2025-03-31NewEdge Investment Solutions0.04910.000110000100000
2025-03-31Atlantic Trust Group, LLC0.016203300-600-15.3846
2025-03-31Advisor Group Holdings, Inc.0.01470300030000
2025-03-31HARBOUR INVESTMENTS, INC.0.00490100000
2025-03-31Atala Financial Inc0.00250.000250000
Total 4.62920.0259942784-401131-42.5%

4.9.2. Funds holding Biomerica Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31JNL Multi-Manager Small Cap Growth A0.18830.00138358-254941-86.9219
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr0.82990.00012112700
2025-03-31Victory Small Cap Stock0.080.001216301-72627-81.6694
2025-04-30Fidelity Extended Market Index0.47440.000112077-116-0.9514
2025-03-31Granahan Inv Mgt Sm-Cap Core Gr0.05840.003911884-77044-86.6364
2025-03-31Granahan Small Cap Select0.05840.017511884-77044-86.6364
2025-03-31NT Ext Equity Mkt Idx Fd - L0.05090.00011036800
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.03970.0001809200
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03090.00016299-115-1.793
2025-04-30Fidelity Series Total Market Index0.107102726-1-0.0367
2025-04-30Spartan Extended Market Index Pool F0.09890.000125181154.7857
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01220.00012490200.8097
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.01210247024700
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01210247024700
2025-04-30Fidelity Total Market Index0.067501719-1-0.0581
2025-03-31Northern Trust Extended Eq Market Idx0.00640.00011296-9072-87.5
2025-04-30Spartan Total Market Index Pool G0.042301078558107.3077
2025-03-31BNYM Mellon SL Market Completion UC10.00490.0001995-3-0.3006
2025-03-31NT Quality SCC US Fund - L0.00240.000248900
2025-05-31State St US Ttl Mkt Indx NL Cl A0.0059015000
Total 2.18270.0247154791-485331-313.5%

5.3. Insider Transactions

Insiders are holding 10.133% of the shares of Biomerica Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-24Zackary S IraniBUY6212.88
2023-05-12Zackary S IraniBUY2129.36
2023-05-09Zackary S IraniBUY3711.12
2023-04-28Zackary S IraniBUY22510.72
2023-04-26Zackary S IraniBUY87510.08
2023-01-27Allen BarbieriBUY19223.52
2023-01-26Catherine CosteBUY27323.68
2023-01-24Zackary S IraniBUY25022.48
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-02-28. Currency in USD. All numbers in thousands.

Summary
Total Assets7,376
Total Liabilities1,842
Total Stockholder Equity5,534
 As reported
Total Liabilities 1,842
Total Stockholder Equity+ 5,534
Total Assets = 7,376

Assets

Total Assets7,376
Total Current Assets6,204
Long-term Assets1,172
Total Current Assets
Cash And Cash Equivalents 3,058
Net Receivables 1,268
Inventory 1,655
Other Current Assets 223
Total Current Assets  (as reported)6,204
Total Current Assets  (calculated)6,204
+/-0
Long-term Assets
Property Plant Equipment 660
Long Term Investments 165
Intangible Assets 234
Long-term Assets Other 113
Long-term Assets  (as reported)1,172
Long-term Assets  (calculated)1,172
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,649
Long-term Liabilities193
Total Stockholder Equity5,534
Total Current Liabilities
Short-term Debt 350
Other Current Liabilities 1,244
Total Current Liabilities  (as reported)1,649
Total Current Liabilities  (calculated)1,594
+/- 55
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt193
Long-term Liabilities  (as reported)193
Long-term Liabilities  (calculated)193
+/-0
Total Stockholder Equity
Common Stock1,629
Retained Earnings -51,624
Accumulated Other Comprehensive Income -113
Other Stockholders Equity 55,642
Total Stockholder Equity (as reported)5,534
Total Stockholder Equity (calculated)5,534
+/-0
Other
Capital Stock1,629
Cash and Short Term Investments 3,058
Common Stock Shares Outstanding 17,121
Current Deferred Revenue55
Liabilities and Stockholders Equity 7,376
Net Debt -2,515
Net Invested Capital 5,534
Net Working Capital 4,555
Property Plant and Equipment Gross 3,247
Short Long Term Debt Total 543



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-02-282024-11-302024-08-312024-05-312024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-11-302004-08-312004-05-312004-02-292003-11-302003-08-312003-05-312003-02-282002-11-302002-08-312002-05-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-301999-08-311999-05-311999-02-281998-11-301998-08-311998-05-311998-02-281997-11-301997-08-311997-05-311997-02-281996-11-301996-08-311996-05-311996-02-291995-11-301995-08-311995-05-311995-02-281994-11-301994-08-311994-05-311994-02-281993-11-301993-08-311993-05-311993-02-281992-11-301992-08-311992-05-311992-02-291991-11-301991-08-311991-05-311991-02-281990-11-301990-08-311990-05-311990-02-281989-11-301989-08-311989-05-311989-02-281988-11-301988-08-311988-05-311988-02-291987-11-301987-08-311987-05-311987-02-281986-11-301986-08-311986-05-311986-02-281985-11-301985-08-31
> Total Assets 
0
0
0
7,500
0
0
0
6,300
0
0
0
4,800
0
0
4,400
3,800
4,100
0
3,300
9,000
8,700
8,500
7,900
7,300
7,200
7,000
6,700
6,400
6,300
6,500
6,300
6,300
5,900
5,900
6,100
6,300
5,900
5,700
5,600
5,800
5,700
5,700
5,900
6,100
6,300
6,300
7,500
7,400
7,500
7,700
7,600
7,500
7,700
7,500
7,400
7,800
9,400
8,800
7,905
6,735
6,524
6,358
6,102
5,347
5,427
5,201
5,360
5,277
4,914
4,997
5,113
5,113
5,381
5,254
5,541
5,568
5,649
5,817
5,840
5,791
6,018
6,682
2,346
2,428
2,549
2,659
2,807
3,225
3,963
4,078
4,132
5,108
5,154
5,041
5,274
5,152
5,163
4,910
5,119
5,015
4,873
4,784
4,858
4,955
4,971
5,075
5,544
5,571
5,980
6,058
6,111
6,395
6,205
5,827
6,271
6,470
6,047
5,928
5,832
6,124
6,075
5,942
5,876
5,727
5,610
5,585
5,477
5,018
4,913
4,831
4,759
5,223
4,876
5,429
5,068
5,245
6,724
7,039
8,215
17,260
15,892
14,478
13,348
11,819
11,516
14,809
17,560
11,374
11,050
9,908
8,210
14,454
13,219
11,831
10,342
9,254
7,870
7,274
7,376
7,3767,2747,8709,25410,34211,83113,21914,4548,2109,90811,05011,37417,56014,80911,51611,81913,34814,47815,89217,2608,2157,0396,7245,2455,0685,4294,8765,2234,7594,8314,9135,0185,4775,5855,6105,7275,8765,9426,0756,1245,8325,9286,0476,4706,2715,8276,2056,3956,1116,0585,9805,5715,5445,0754,9714,9554,8584,7844,8735,0155,1194,9105,1635,1525,2745,0415,1545,1084,1324,0783,9633,2252,8072,6592,5492,4282,3466,6826,0185,7915,8405,8175,6495,5685,5415,2545,3815,1135,1134,9974,9145,2775,3605,2015,4275,3476,1026,3586,5246,7357,9058,8009,4007,8007,4007,5007,7007,5007,6007,7007,5007,4007,5006,3006,3006,1005,9005,7005,7005,8005,6005,7005,9006,3006,1005,9005,9006,3006,3006,5006,3006,4006,7007,0007,2007,3007,9008,5008,7009,0003,30004,1003,8004,400004,8000006,3000007,500000
   > Total Current Assets 
0
0
0
7,100
0
0
0
5,700
0
0
0
4,400
0
0
2,100
1,600
1,900
0
1,100
5,900
5,700
5,400
4,900
4,800
4,800
4,700
4,600
4,600
4,500
4,800
4,700
4,500
4,200
4,300
4,100
4,800
4,400
4,200
4,200
4,500
4,400
4,500
4,700
4,900
5,300
5,300
6,500
6,300
6,400
6,700
6,500
6,500
6,700
6,500
6,400
6,800
8,400
7,800
6,966
5,809
5,604
5,429
5,202
4,677
4,819
4,622
4,818
4,882
4,552
4,590
4,707
4,707
4,704
4,521
4,752
4,750
4,802
4,953
4,955
4,287
4,392
4,690
2,193
1,846
1,913
2,044
2,213
2,610
3,314
3,377
3,262
4,538
4,562
4,440
4,699
4,555
4,537
3,998
4,183
4,093
3,948
3,777
3,857
3,886
3,879
4,014
4,414
4,487
4,885
4,842
4,938
5,253
5,105
4,699
5,061
4,913
4,538
4,467
4,431
4,466
4,464
4,158
3,981
4,835
4,769
4,772
4,644
4,210
4,171
4,099
4,049
4,484
4,117
4,688
4,329
4,495
4,114
4,511
5,739
14,767
13,120
11,947
10,785
9,231
8,946
12,403
15,231
9,428
9,168
8,099
6,482
12,797
11,574
10,265
8,846
7,731
6,445
5,945
6,204
6,2045,9456,4457,7318,84610,26511,57412,7976,4828,0999,1689,42815,23112,4038,9469,23110,78511,94713,12014,7675,7394,5114,1144,4954,3294,6884,1174,4844,0494,0994,1714,2104,6444,7724,7694,8353,9814,1584,4644,4664,4314,4674,5384,9135,0614,6995,1055,2534,9384,8424,8854,4874,4144,0143,8793,8863,8573,7773,9484,0934,1833,9984,5374,5554,6994,4404,5624,5383,2623,3773,3142,6102,2132,0441,9131,8462,1934,6904,3924,2874,9554,9534,8024,7504,7524,5214,7044,7074,7074,5904,5524,8824,8184,6224,8194,6775,2025,4295,6045,8096,9667,8008,4006,8006,4006,5006,7006,5006,5006,7006,4006,3006,5005,3005,3004,9004,7004,5004,4004,5004,2004,2004,4004,8004,1004,3004,2004,5004,7004,8004,5004,6004,6004,7004,8004,8004,9005,4005,7005,9001,10001,9001,6002,100004,4000005,7000007,100000
       Cash And Cash Equivalents 
0
0
0
6,200
0
0
0
4,700
0
0
0
3,700
0
0
0
0
0
0
0
0
0
100
200
200
100
100
200
300
500
500
200
300
400
600
400
800
600
600
800
700
400
400
600
600
1,000
900
1,900
1,700
1,800
1,800
1,800
1,800
1,800
1,800
1,700
1,700
3,400
2,600
1,648
634
658
247
234
136
149
54
119
329
271
490
580
580
288
297
179
352
141
223
221
352
227
150
47
120
90
38
66
517
991
808
822
2,022
1,961
1,788
1,529
1,596
1,692
1,403
1,130
1,055
813
972
904
989
1,021
966
898
1,077
1,299
1,194
2,319
2,470
2,085
1,648
1,666
1,509
1,647
1,674
1,172
1,088
893
643
859
1,889
1,817
1,611
1,542
1,225
1,081
818
597
1,205
584
1,125
918
687
808
851
2,392
8,641
6,964
5,684
5,273
4,199
4,997
7,199
10,174
5,917
6,075
5,067
3,345
9,719
7,988
7,134
5,319
4,170
2,820
2,372
3,058
3,0582,3722,8204,1705,3197,1347,9889,7193,3455,0676,0755,91710,1747,1994,9974,1995,2735,6846,9648,6412,3928518086879181,1255841,2055978181,0811,2251,5421,6111,8171,8898596438931,0881,1721,6741,6471,5091,6661,6482,0852,4702,3191,1941,2991,0778989661,0219899049728131,0551,1301,4031,6921,5961,5291,7881,9612,02282280899151766389012047150227352221223141352179297288580580490271329119541491362342476586341,6482,6003,4001,7001,7001,8001,8001,8001,8001,8001,8001,7001,9009001,0006006004004007008006006008004006004003002005005003002001001002002001000000000003,7000004,7000006,200000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
98
99
74
84
55
42
33
13
1
3
1
1
0
0
55
35
34
26
21
19
13
8
5
4
400
3
3
2
1
1
1
1
0
0
0
1
101
100
100
0
0
0
0
0
0
165,324
165,324
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
165
165
0
0
165
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001650016516500000000000000000000000000000000000165,324165,324000000100100101100011112334004581319212634355500113113334255847499981001001000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
400
0
0
0
300
0
0
0
200
0
0
300
200
400
0
200
2,500
2,200
2,100
2,000
2,000
1,700
1,600
1,300
1,300
1,400
1,300
1,300
1,500
1,500
1,500
1,500
1,500
1,500
1,600
1,600
1,600
1,700
1,500
1,400
1,800
1,700
1,700
1,900
1,500
1,500
1,900
1,800
1,600
1,700
1,500
1,500
1,600
1,400
1,500
1,451
1,702
1,657
1,675
1,445
1,544
1,555
1,505
1,661
1,507
1,279
1,285
1,541
1,541
1,498
1,357
1,750
1,517
1,601
1,579
1,760
1,722
1,796
2,050
533
561
574
740
677
505
742
664
666
614
524
576
830
641
540
539
977
1,018
1,040
875
993
747
865
1,132
1,343
1,201
1,373
1,510
513
872
903
822
1,172
1,448
788
564
931
1,112
1,214
1,173
920
969
969
1,141
1,072
1,060
1,047
1,055
1,158
800
1,014
1,261
1,077
1,455
859
1,283
962
1,766
1,583
1,612
1,878
1,455
772
1,125
1,159
774
932
850
755
722
1,430
1,067
1,130
947
1,551
1,326
1,268
1,2681,3261,5519471,1301,0671,4307227558509327741,1591,1257721,4551,8781,6121,5831,7669621,2838591,4551,0771,2611,0148001,1581,0551,0471,0601,0721,1419699699201,1731,2141,1129315647881,4481,1728229038725131,5101,3731,2011,3431,1328657479938751,0401,0189775395406418305765246146666647425056777405745615332,0501,7961,7221,7601,5791,6011,5171,7501,3571,4981,5411,5411,2851,2791,5071,6611,5051,5551,5441,4451,6751,6571,7021,4511,5001,4001,6001,5001,5001,7001,6001,8001,9001,5001,5001,9001,7001,7001,8001,4001,5001,7001,6001,6001,6001,5001,5001,5001,5001,5001,5001,3001,3001,4001,3001,3001,6001,7002,0002,0002,1002,2002,500200040020030000200000300000400000
       Other Current Assets 
0
0
0
200
0
0
0
100
0
0
0
100
0
0
1,400
1,000
1,200
0
600
600
500
500
500
400
600
500
700
700
200
500
700
500
400
400
500
900
700
500
400
400
300
500
600
400
400
400
400
700
500
500
500
0
400
300
200
300
300
500
542
479
385
473
391
89
89
96
113
122
143
118
81
81
145
176
152
182
172
217
123
115
116
134
46
58
75
49
58
126
138
236
94
137
122
82
158
219
247
107
118
230
219
114
124
365
258
246
310
388
391
500
401
341
325
330
285
191
222
239
217
164
248
105
102
227
132
139
212
392
251
400
341
601
311
187
507
405
242
186
395
1,509
471
453
774
370
315
1,097
667
321
239
121
318
300
279
446
268
238
132
458
223
2234581322382684462793003181212393216671,0973153707744534711,509395186242405507187311601341400251392212139132227102105248164217239222191285330325341401500391388310246258365124114219230118107247219158821221379423613812658497558461341161151232171721821521761458181118143122113968989391473385479542500300300200300400050050050070040040040040060050030040040050070090050040040050070050020070070050060040050050050060060001,2001,0001,40000100000100000200000
   > Long-term Assets 
0
0
0
400
0
0
0
600
0
0
0
400
0
0
2,300
2,200
2,200
0
2,200
3,100
3,000
3,100
3,000
2,500
2,400
2,300
2,100
1,800
1,800
1,700
1,600
1,800
1,700
1,600
2,000
1,500
1,500
1,500
1,400
1,300
1,300
1,200
1,200
1,200
1,000
1,000
1,000
1,100
1,100
1,000
1,100
0
1,000
1,000
1,000
1,000
1,000
1,000
939
927
920
929
900
670
608
580
542
395
362
407
406
406
678
733
789
818
847
864
885
1,504
1,626
1,992
153
582
636
615
593
614
649
701
870
570
591
601
574
597
626
912
936
922
925
1,007
1,001
1,069
1,093
1,061
1,130
1,084
1,095
1,216
1,172
1,142
1,100
1,128
1,210
1,557
1,510
1,461
1,401
1,659
1,611
1,784
1,895
891
842
813
833
808
742
732
710
739
759
741
739
750
2,610
2,528
2,476
2,493
2,772
2,531
2,563
2,588
2,570
2,406
2,329
1,946
1,882
1,809
1,728
1,657
1,645
1,566
1,496
1,523
1,425
1,329
1,172
1,1721,3291,4251,5231,4961,5661,6451,6571,7281,8091,8821,9462,3292,4062,5702,5882,5632,5312,7722,4932,4762,5282,6107507397417597397107327428088338138428911,8951,7841,6111,6591,4011,4611,5101,5571,2101,1281,1001,1421,1721,2161,0951,0841,1301,0611,0931,0691,0011,0079259229369126265975746015915708707016496145936156365821531,9921,6261,5048858648478187897336784064064073623955425806086709009299209279391,0001,0001,0001,0001,0001,00001,1001,0001,1001,1001,0001,0001,0001,2001,2001,2001,3001,3001,4001,5001,5001,5002,0001,6001,7001,8001,6001,7001,8001,8002,1002,3002,4002,5003,0003,1003,0003,1002,20002,2002,2002,30000400000600000400000
       Property Plant Equipment 
0
0
0
300
0
0
0
300
0
0
0
200
0
0
200
100
100
0
100
1,300
1,300
1,400
1,300
1,300
1,200
1,100
1,000
1,000
900
800
800
800
700
700
600
500
500
500
600
500
500
500
500
500
400
400
400
500
500
500
500
500
400
400
400
400
400
500
471
470
483
513
497
318
291
266
247
228
214
255
265
265
535
593
659
717
742
766
790
817
941
1,919
123
127
182
190
180
168
160
179
350
370
381
387
381
367
368
566
573
562
538
562
547
567
571
545
597
585
605
734
692
655
621
652
640
614
572
532
485
445
411
395
398
381
344
332
368
332
321
326
319
351
362
349
346
351
2,202
2,127
2,069
1,991
1,946
1,885
1,845
1,864
1,778
1,701
1,631
1,515
1,463
1,406
1,329
1,248
1,182
1,101
1,011
943
850
755
660
6607558509431,0111,1011,1821,2481,3291,4061,4631,5151,6311,7011,7781,8641,8451,8851,9461,9912,0692,1272,2023513463493623513193263213323683323443813983954114454855325726146406526216556927346055855975455715675475625385625735663683673813873813703501791601681801901821271231,9199418177907667427176595935352652652552142282472662913184975134834704715004004004004004005005005005005004004004005005005005005006005005005006007007008008008009001,0001,0001,1001,2001,3001,3001,4001,3001,300100010010020000200000300000300000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
498
499
0
0
0
0
0
0
0
0
0
0
0
0
0000000000004994980000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
16516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
1,500
1,400
1,400
1,200
1,200
1,100
1,100
900
900
900
800
800
800
800
800
700
700
700
700
600
600
600
600
600
500
500
500
500
500
500
400
500
500
500
500
400
400
400
390
367
362
342
321
297
274
262
239
116
97
99
85
85
60
51
41
49
23
17
15
13
12
10
9
8
6
5
4
3
1
0
0
0
0
0
0
30
33
34
45
84
107
139
158
177
195
187
203
195
186
177
173
165
158
154
248
382
370
360
340
321
304
285
265
249
233
212
193
174
157
139
122
99
105
98
95
107
114
110
114
169
216
218
269
295
360
-109
-113
170
161
158
155
165
202
204
216
212
207
236
234
234236207212216204202165155158161170-113-1093602952692182161691141101141079598105991221391571741932122332492652853043213403603703822481541581651731771861952031871951771581391078445343330000000134568910121315172349415160858599971162392622742973213423623673904004004005005005005004005005005005005005006006006006006007007007007008008008008008009009009001,1001,1001,2001,2001,4001,4001,5001,5000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
468
456
437
416
403
352
317
313
296
167
148
152
141
138
143
140
129
101
105
98
95
687
685
674
30
455
454
425
414
447
489
522
520
200
210
214
193
230
258
346
363
360
388
445
454
502
521
516
533
499
490
482
480
487
479
475
570
942
937
929
915
1,213
1,200
1,389
1,497
511
498
481
465
476
421
405
391
123
127
130
132
127
129
125
128
168
445
2,024
283
264
267
150
147
0
94
80
79
79
96
0
0
0
0
0
0
000000967979809401471502672642832,0244451681281251291271321301271233914054214764654814985111,4971,3891,2001,2139159299379425704754794874804824904995335165215024544453883603633462582301932142102005205224894474144254544553067468568795981051011291401431381411521481672963133173524034164374564680000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
85
359
359
359
359
670
670
873
998
41
41
0
0
41
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000041004141998873670670359359359359858500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
1,400
0
0
0
1,700
0
0
0
700
0
0
600
500
800
0
500
4,400
4,200
4,400
4,400
4,800
4,800
4,800
4,600
4,100
4,100
3,600
3,500
3,500
3,100
3,200
2,800
3,000
2,700
2,500
2,400
2,600
2,300
2,000
2,200
2,000
2,000
2,000
2,000
1,500
1,500
1,700
1,500
1,300
1,500
1,500
1,500
1,600
1,600
1,700
1,752
1,828
2,410
2,319
2,020
1,827
2,277
2,082
2,185
1,981
1,693
1,894
1,974
1,974
2,305
2,297
2,460
2,054
2,206
2,475
2,443
2,258
2,151
2,832
1,493
1,365
1,395
1,421
1,452
1,472
1,266
1,313
1,201
1,224
1,095
1,068
1,012
804
804
832
896
952
823
722
715
625
524
422
663
592
710
546
584
560
537
401
543
556
349
467
483
524
539
469
487
506
445
567
657
529
627
804
759
897
798
1,017
1,113
1,264
3,100
3,663
3,534
3,047
3,312
3,329
2,748
2,592
2,713
5,908
7,803
3,050
2,728
2,665
2,224
2,730
2,451
2,448
2,534
2,663
2,524
2,160
1,842
1,8422,1602,5242,6632,5342,4482,4512,7302,2242,6652,7283,0507,8035,9082,7132,5922,7483,3293,3123,0473,5343,6633,1001,2641,1131,0177988977598046275296575674455064874695395244834673495565434015375605845467105926634225246257157228239528968328048041,0121,0681,0951,2241,2011,3131,2661,4721,4521,4211,3951,3651,4932,8322,1512,2582,4432,4752,2062,0542,4602,2972,3051,9741,9741,8941,6931,9812,1852,0822,2771,8272,0202,3192,4101,8281,7521,7001,6001,6001,5001,5001,5001,3001,5001,7001,5001,5002,0002,0002,0002,0002,2002,0002,3002,6002,4002,5002,7003,0002,8003,2003,1003,5003,5003,6004,1004,1004,6004,8004,8004,8004,4004,4004,2004,4005000800500600007000001,7000001,400000
   > Total Current Liabilities 
0
0
0
1,200
0
0
0
1,500
0
0
0
500
0
0
600
500
800
0
600
3,200
3,200
3,400
4,100
4,800
4,700
4,700
4,500
4,100
4,000
3,500
3,400
3,400
3,100
3,200
2,900
3,100
2,700
1,500
1,400
1,600
1,500
1,600
1,800
1,700
1,800
1,900
1,900
1,500
1,500
1,700
1,500
1,400
1,500
1,400
1,500
1,600
1,500
1,600
1,752
1,828
2,410
2,319
2,020
1,732
2,052
1,822
1,875
1,636
1,355
1,894
1,974
1,974
2,042
2,060
2,383
2,054
2,206
2,475
2,443
2,258
2,151
2,569
1,493
1,356
1,387
1,415
1,447
1,412
1,202
1,175
1,072
1,109
994
980
922
724
735
733
787
917
799
710
644
625
524
422
663
592
710
546
584
560
537
401
543
556
349
467
483
524
539
469
487
506
445
567
657
529
627
804
759
897
798
1,017
1,113
1,264
1,369
1,984
1,910
1,477
1,801
1,874
1,352
1,300
1,482
4,741
6,698
2,011
1,758
1,763
1,395
1,945
1,746
1,822
1,991
2,204
2,151
1,876
1,649
1,6491,8762,1512,2041,9911,8221,7461,9451,3951,7631,7582,0116,6984,7411,4821,3001,3521,8741,8011,4771,9101,9841,3691,2641,1131,0177988977598046275296575674455064874695395244834673495565434015375605845467105926634225246256447107999177877337357249229809941,1091,0721,1751,2021,4121,4471,4151,3871,3561,4932,5692,1512,2582,4432,4752,2062,0542,3832,0602,0421,9741,9741,8941,3551,6361,8751,8222,0521,7322,0202,3192,4101,8281,7521,6001,5001,6001,5001,4001,5001,4001,5001,7001,5001,5001,9001,9001,8001,7001,8001,6001,5001,6001,4001,5002,7003,1002,9003,2003,1003,4003,4003,5004,0004,1004,5004,7004,7004,8004,1003,4003,2003,2006000800500600005000001,5000001,200000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,600
1,400
1,500
2,400
2,600
2,700
2,700
2,400
2,200
2,200
2,000
2,000
2,200
2,100
2,000
1,900
1,800
1,600
300
300
400
400
400
400
500
500
300
300
400
300
300
200
100
100
200
200
200
200
200
220
160
910
723
263
140
160
173
117
96
1
0
329
329
75
86
25
317
317
467
513
476
320
586
268
265
253
246
238
172
158
188
180
100
53
2
44
42
43
44
44
45
46
47
47
35
24
12
0
43
43
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
390
401
412
212
442
448
458
656
666
335
339
682
688
694
699
297
306
622
638
326
668
342
350
3503426683266386223062976996946886823393356666564584484422124124013900000000000000000000000000004343012243547474645444443424425310018018815817223824625326526858632047651346731731725867532932901961171731601402637239101602202002002002002001001002003003004003003005005004004004004003003001,6001,8001,9002,0002,1002,2002,0002,0002,2002,2002,4002,7002,7002,6002,4001,5001,4001,6000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
400
300
0
200
1,600
1,800
1,800
1,600
1,400
2,000
2,000
1,800
1,500
1,800
1,500
1,300
700
600
800
600
600
500
500
400
600
500
700
600
700
700
600
800
700
700
900
900
0
1,000
900
900
1,000
900
1,100
1,265
1,314
1,172
1,142
1,150
931
1,248
980
1,069
906
743
860
956
956
1,177
1,115
1,205
983
1,063
1,136
1,110
1,083
1,143
1,282
678
581
634
702
721
666
572
564
402
474
469
479
402
264
304
345
422
402
480
306
275
246
500
163
452
188
338
226
195
282
216
168
317
386
178
250
312
357
375
293
312
326
263
367
483
336
419
586
534
656
548
765
853
1,000
944
1,345
1,268
833
1,271
1,258
756
431
641
1,581
2,609
736
671
670
387
344
713
783
885
288
1,089
0
0
001,0892888857837133443876706717362,6091,5816414317561,2581,2718331,2681,3459441,0008537655486565345864193364833672633263122933753573122501783863171682162821952263381884521635002462753064804024223453042644024794694744025645726667217026345816781,2821,1431,0831,1101,1361,0639831,2051,1151,1779569568607439061,0699801,2489311,1501,1421,1721,3141,2651,1009001,0009009001,00009009007007008006007007006007005006004005005006006008006007001,3001,5001,8001,5001,8002,0002,0001,4001,6001,8001,8001,600200030040030000000000000000
       Other Current Liabilities 
0
0
0
1,200
0
0
0
1,500
0
0
0
500
0
0
300
100
500
0
400
0
0
100
100
800
0
0
300
400
0
0
100
500
400
400
400
700
600
700
700
600
600
500
800
500
600
1,000
800
400
500
500
400
0
400
300
400
400
400
300
266
353
328
454
606
661
644
669
689
634
611
1,034
689
689
790
859
1,153
754
825
872
821
699
689
701
547
511
501
467
487
573
472
424
491
536
472
499
476
681
692
690
743
470
754
664
597
343
500
410
186
302
352
320
390
278
321
233
226
170
171
217
172
167
164
176
175
180
182
199
174
192
208
219
225
241
249
252
260
265
35
239
230
432
88
168
138
213
175
664
524
849
346
651
171
1,244
667
654
681
1,505
309
1,449
1,244
1,2441,4493091,5056816546671,24417165134684952466417521313816888432230239352652602522492412252192081921741991821801751761641671722171711702262333212783903203523021864105003435976647544707436906926814764994725364914244725734874675015115477016896998218728257541,1538597906896891,03461163468966964466160645432835326630040040040030040004005005004008001,0006005008005006006007007006007004004004005001000040030000800100100004000500100300005000001,5000001,200000
   > Long-term Liabilities 
0
0
0
200
0
0
0
200
0
0
0
200
0
0
0
0
0
0
-100
1,200
1,000
1,000
300
100
100
100
100
100
100
100
100
100
0
0
-100
-100
0
1,000
1,000
1,000
800
400
400
300
200
100
100
0
0
0
0
0
-100
100
0
0
100
100
0
0
0
0
0
95
225
260
310
345
338
0
0
255
263
237
77
0
0
0
0
0
0
263
0
9
8
7
6
60
65
138
128
115
102
88
90
81
70
99
109
35
24
12
72
451,569
451,569
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,731
1,678
1,624
1,570
1,510
1,455
1,396
1,292
1,231
1,167
1,105
1,038
971
901
829
785
705
626
543
459
373
284
193
1932843734595436267057858299019711,0381,1051,1671,2311,2921,3961,4551,5101,5701,6241,6781,7310000000000000000000000000000000451,569451,5697212243510999708190881021151281386560678902630000007723726325500338345310260225950000010010000100-100000001001002003004004008001,0001,0001,0000-100-100001001001001001001001001001003001,0001,0001,200-100000000200000200000200000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
85
359
359
359
359
670
670
873
998
41
41
0
0
41
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000041004141998873670670359359359359858500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41
63
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000063410000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
6,100
0
0
0
4,600
0
0
0
4,100
0
0
3,700
3,300
3,300
0
2,800
2,800
2,700
2,700
2,400
1,800
1,700
1,600
1,400
1,300
1,200
1,200
1,000
1,200
1,100
1,100
1,600
1,600
1,500
1,400
1,400
1,400
1,500
1,700
1,800
2,000
2,200
2,200
3,400
3,600
3,700
3,700
3,800
0
3,700
3,600
3,500
6,200
5,500
4,900
4,011
2,796
2,073
2,032
2,059
1,473
1,199
1,111
1,132
1,211
1,133
990
1,005
1,005
1,024
898
975
926
877
795
850
1,053
1,064
1,057
854
1,064
1,154
1,237
1,355
1,753
2,696
2,765
2,931
3,884
4,058
3,973
4,261
4,348
4,359
4,078
4,222
4,063
4,050
4,062
4,142
4,330
4,448
4,653
4,882
4,979
5,270
5,513
5,526
5,835
5,669
5,427
5,728
5,914
5,698
5,461
5,348
5,601
5,536
5,473
5,389
5,220
5,165
5,019
4,820
4,489
4,287
4,027
4,000
4,326
4,078
4,412
3,954
3,981
3,624
3,376
4,681
14,213
12,581
11,149
10,600
9,227
8,803
8,901
9,758
8,325
8,322
7,243
5,986
11,724
10,768
9,383
7,808
6,591
5,346
5,114
5,534
5,5345,1145,3466,5917,8089,38310,76811,7245,9867,2438,3228,3259,7588,9018,8039,22710,60011,14912,58114,2134,6813,3763,6243,9813,9544,4124,0784,3264,0004,0274,2874,4894,8205,0195,1655,2205,3895,4735,5365,6015,3485,4615,6985,9145,7285,4275,6695,8355,5265,5135,2704,9794,8824,6534,4484,3304,1424,0624,0504,0634,2224,0784,3594,3484,2613,9734,0583,8842,9312,7652,6961,7531,3551,2371,1541,0648541,0571,0641,0538507958779269758981,0241,0051,0059901,1331,2111,1321,1111,1991,4732,0592,0322,0732,7964,0114,9005,5006,2003,5003,6003,70003,8003,7003,7003,6003,4002,2002,2002,0001,8001,7001,5001,4001,4001,4001,5001,6001,6001,1001,1001,2001,0001,2001,2001,3001,4001,6001,7001,8002,4002,7002,7002,8002,80003,3003,3003,700004,1000004,6000006,100000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
400
400
363
366
375
389
389
391
404
410
410
438
480
462
421
421
460
460
460
460
460
460
460
460
460
460
460
461
474
475
475
476
479
489
501
519
530
530
530
530
530
533
533
533
533
533
533
549
549
549
553
556
556
558
564
582
582
582
601
603
604
604
604
605
607
607
613
654
654
664
680
681
681
682
690
711
716
743
747
774
782
788
825
939
940
942
984
985
1,001
1,015
1,028
1,029
1,073
1,078
1,079
1,346
1,346
1,346
1,346
1,346
1,346
1,467
1,629
1,6291,4671,3461,3461,3461,3461,3461,3461,0791,0781,0731,0291,0281,0151,0019859849429409398257887827747477437167116906826816816806646546546136076076056046046046036015825825825645585565565535495495495335335335335335335305305305305305195014894794764754754744614604604604604604604604604604604604214214624804384104104043913893893753663634004003000000000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity000000000000000-28,395-26,900-25,060-23,5750-21,439-20,578-20,093-19,587-18,801-18,123-17,645-17,194-16,526-16,204-15,935-15,728-15,382-15,078-14,875-14,819-13,594-13,459-13,392-13,319-13,563-13,445-13,207-12,988-13,157-13,18300000000-13,74000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-700
0
0
0
-900
0
0
0
-900
0
0
-900
-900
-900
0
-900
-2,600
-2,600
-2,600
-2,600
-2,600
-2,600
-2,600
-2,600
-2,400
-2,400
-2,400
-2,400
-2,600
-2,600
-2,600
-2,600
-2,600
-2,600
-2,600
-2,600
-2,500
-2,600
-2,600
-2,700
-2,700
-2,700
-2,500
-2,600
-2,600
-2,600
-2,700
-2,700
-2,600
-2,700
-2,700
-2,700
-2,800
-2,800
-2,800
-18
-2,926
-13
-4
48
-3,033
-14
-15
-21
-20
-22
-22
44
44
32
13
26
18
13
11
6
1
-3
-4
-240
-177
-227
-255
-264
-230
-195
-175
-175
-4
-7
-9
-9
-2
-2
-2
-3
-4
-4
-4
-5
-4
-5
-6
-6
-6
-6
-7
-9
-9
-9
-9
-10
-10
-11
-12
-12
-12
-13
-14
-14
-14
-14
-14
-15
-16
-17
-21
-22
-26
-27
-32
-34
-37
-40
-42
-41
-40
-42
-43
-49
-48
-54
-58
-61
-74
-86
-95
-111
-110
-104
-104
-102
-102
-108
-112
-113
-113-112-108-102-102-104-104-110-111-95-86-74-61-58-54-48-49-43-42-40-41-42-40-37-34-32-27-26-22-21-17-16-15-14-14-14-14-14-13-12-12-12-11-10-10-9-9-9-9-7-6-6-6-6-5-4-5-4-4-4-3-2-2-2-9-9-7-4-175-175-195-230-264-255-227-177-240-4-3161113182613324444-22-22-20-21-15-14-3,03348-4-13-2,926-18-2,800-2,800-2,800-2,700-2,700-2,700-2,600-2,700-2,700-2,600-2,600-2,600-2,500-2,700-2,700-2,700-2,600-2,600-2,500-2,600-2,600-2,600-2,600-2,600-2,600-2,600-2,600-2,400-2,400-2,400-2,400-2,600-2,600-2,600-2,600-2,600-2,600-2,600-2,600-9000-900-900-90000-900000-900000-700000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,643
0
0
0
0
0
0
0
0
18,037
18,294
18,309
18,313
18,314
18,319
18,327
18,333
18,338
18,384
19,400
19,400
19,447
19,536
19,552
19,557
19,569
19,891
20,844
21,035
21,823
22,049
22,830
22,975
23,223
26,447
0
35,231
35,285
36,564
36,685
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000036,68536,56435,28535,231026,44723,22322,97522,83022,04921,82321,03520,84419,89119,56919,55719,55219,53619,44719,40019,40018,38418,33818,33318,32718,31918,31418,31318,30918,29418,0370000000017,64300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
11,500
0
0
0
11,500
0
0
0
11,400
0
0
11,500
11,500
11,600
0
11,700
13,300
13,300
13,300
13,300
13,300
13,300
13,300
13,400
13,600
13,500
13,700
13,600
14,100
14,100
14,100
14,700
14,400
14,300
14,200
14,200
14,100
14,200
14,300
14,400
14,400
14,500
14,200
15,400
15,500
15,400
15,500
15,600
0
15,500
15,500
15,500
17,900
15,300
15,400
15,418
0
15,734
16,262
16,724
0
16,881
16,931
16,973
16,982
16,998
17,056
17,073
17,073
17,204
17,211
17,211
17,125
17,131
17,120
17,109
17,107
17,058
17,050
17,054
17,064
17,127
17,131
17,136
17,255
17,275
17,310
17,341
17,410
17,433
17,451
17,463
17,503
17,506
17,529
17,540
17,549
17,549
17,560
17,568
17,643
17,643
17,654
17,698
17,738
17,738
17,742
17,788
18,034
18,036
18,037
18,294
18,309
18,313
18,314
18,319
18,327
18,333
18,338
18,384
19,400
19,400
19,447
19,536
19,552
19,557
19,569
19,858
20,834
21,035
21,823
22,043
22,830
22,975
23,208
25,290
35,214
35,231
35,285
36,564
36,685
39,945
41,159
42,109
42,447
44,485
45,035
45,443
52,705
52,875
52,997
53,338
53,542
53,619
54,220
55,642
55,64254,22053,61953,54253,33852,99752,87552,70545,44345,03544,48542,44742,10941,15939,94536,68536,56435,28535,23135,21425,29023,20822,97522,83022,04321,82321,03520,83419,85819,56919,55719,55219,53619,44719,40019,40018,38418,33818,33318,32718,31918,31418,31318,30918,29418,03718,03618,03417,78817,74217,73817,73817,69817,65417,64317,64317,56817,56017,54917,54917,54017,52917,50617,50317,46317,45117,43317,41017,34117,31017,27517,25517,13617,13117,12717,06417,05417,05017,05817,10717,10917,12017,13117,12517,21117,21117,20417,07317,07317,05616,99816,98216,97316,93116,881016,72416,26215,734015,41815,40015,30017,90015,50015,50015,500015,60015,50015,40015,50015,40014,20014,50014,40014,40014,30014,20014,10014,20014,20014,30014,40014,70014,10014,10014,10013,60013,70013,50013,60013,40013,30013,30013,30013,30013,30013,30013,30011,700011,60011,50011,5000011,40000011,50000011,500000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-05-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue5,415
Cost of Revenue-4,804
Gross Profit611611
 
Operating Income (+$)
Gross Profit611
Operating Expense-6,978
Operating Income-6,367-6,367
 
Operating Expense (+$)
Research Development1,491
Selling General Administrative5,487
Selling And Marketing Expenses0
Operating Expense6,9786,978
 
Net Interest Income (+$)
Interest Income431
Interest Expense-0
Other Finance Cost-0
Net Interest Income431
 
Pretax Income (+$)
Operating Income-6,367
Net Interest Income431
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,936-6,798
EBIT - interestExpense = -6,367
-5,936
-5,978
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-6,367-5,936
Earnings Before Interest and Taxes (EBITDA)-5,993
 
After tax Income (+$)
Income Before Tax-5,936
Tax Provision-42
Net Income From Continuing Ops-5,978-5,978
Net Income-5,978
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses11,782
Total Other Income/Expenses Net431-431
 

Technical Analysis of Biomerica
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biomerica. The general trend of Biomerica is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biomerica's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biomerica Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biomerica Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.62 < 3.95 < 4.2099.

The bearish price targets are: 3.0093 > 3.0019 > 2.88.

Know someone who trades $BMRA? Share this with them.πŸ‘‡

Biomerica Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biomerica Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biomerica Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biomerica Inc. The current macd is -0.0270395.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biomerica price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biomerica. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biomerica price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biomerica Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiomerica Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biomerica Inc. The current adx is 15.37.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biomerica shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Biomerica Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biomerica Inc. The current sar is 3.78.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biomerica Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biomerica Inc. The current rsi is 44.70. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Biomerica Inc Daily Relative Strength Index (RSI) ChartBiomerica Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biomerica Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biomerica price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biomerica Inc Daily Stochastic Oscillator ChartBiomerica Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biomerica Inc. The current cci is -69.52250566.

Biomerica Inc Daily Commodity Channel Index (CCI) ChartBiomerica Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biomerica Inc. The current cmo is -13.36527216.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biomerica Inc Daily Chande Momentum Oscillator (CMO) ChartBiomerica Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biomerica Inc. The current willr is -70.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biomerica is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biomerica Inc Daily Williams %R ChartBiomerica Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Biomerica Inc.

Biomerica Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biomerica Inc. The current atr is 0.24979097.

Biomerica Inc Daily Average True Range (ATR) ChartBiomerica Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biomerica Inc. The current obv is 486,833,079.

Biomerica Inc Daily On-Balance Volume (OBV) ChartBiomerica Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biomerica Inc. The current mfi is 88.77.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Biomerica Inc Daily Money Flow Index (MFI) ChartBiomerica Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biomerica Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-02-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Biomerica Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biomerica Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.704
Ma 20Greater thanMa 503.224
Ma 50Greater thanMa 1003.338
Ma 100Greater thanMa 2004.144
OpenGreater thanClose3.280
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biomerica with someone you think should read this too:
  • Are you bullish or bearish on Biomerica? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biomerica? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biomerica Inc

I send you an email if I find something interesting about Biomerica Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biomerica Inc.

Receive notifications about Biomerica Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.